Form 8-K - Current report:
SEC Accession No. 0001213900-19-019191
Filing Date
2019-09-27
Accepted
2019-09-27 16:35:15
Documents
7
Period of Report
2019-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k0919_citiuspharma.htm 8-K 34044
2 UNDERWRITING AGREEMENT, DATED AS OF SEPTEMBER 25, 2019, f8k0919ex1-1_citiuspharma.htm EX-1.1 252458
3 FORM OF COMMON STOCK PURCHASE WARRANT ISSUED ON SEPTEMBER 27, 2019. f8k0919ex4-1_citiuspharma.htm EX-4.1 97530
4 FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT ISSUED ON SEPTEMBER 27, 2019. f8k0919ex4-2_citiuspharma.htm EX-4.2 121404
5 FORM OF UNDERWRITERS COMMON STOCK PURCHASE WARRANT ISSUED ON SEPTEMBER 27, 2019. f8k0919ex4-3_citiuspharma.htm EX-4.3 104328
6 PRESS RELEASE, DATED SEPTEMBER 25, 2019. f8k0919ex99-1_citiuspharma.htm EX-99.1 11181
7 PRESS RELEASE, DATED SEPTEMBER 27, 2019. f8k0919ex99-2_citiuspharma.htm EX-99.2 10379
  Complete submission text file 0001213900-19-019191.txt   632674
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 191122501
SIC: 2834 Pharmaceutical Preparations